首页 | 本学科首页   官方微博 | 高级检索  
检索        

Mir-7上调增强肺腺癌对吉非替尼敏感性的机制研究
引用本文:赵俊刚,鲁继斌,门万夫,张磊.Mir-7上调增强肺腺癌对吉非替尼敏感性的机制研究[J].现代肿瘤医学,2012,20(6):1113-1116.
作者姓名:赵俊刚  鲁继斌  门万夫  张磊
作者单位:中国医科大学附属盛京医院胸外科,辽宁 沈阳,110004
基金项目:辽宁省博士科研启动基金
摘    要:目的:探索上调Mir-7的表达使肺腺癌A549细胞增强吉非替尼的敏感性及其机制。方法:用lipo-fectamine2000携带Mir-7对A549细胞进行瞬时转染。将A549细胞分为对照组、转染组、吉非替尼组与联合组。MTT法测各组细胞增殖率变化,Transwell检测细胞侵袭性,Real time PCR检测E-Cadherin及N-Cad-herin的mRNA表达的变化,Western blot检测他们的蛋白表达的变化。结果:上调A549细胞中Mir-7的表达与吉非替尼共同作用较单独吉非替尼作用有更显著的抑制作用。用Mir-7转染后,肺腺癌A549细胞的侵袭力下降。转染与吉非替尼联合组E-Cadherin的信使RNA及蛋白的表达变化不大,但N-Cadherin表达下降。结论:上调Mir-7的表达可以增强肺腺癌细胞对吉非替尼的敏感性,其机制可能是过量表达的Mir-7抑制了IGF-1R信号通路及肿瘤上皮细胞间质化。

关 键 词:非小细胞肺癌  吉非替尼  Mir-7  钙黏素

Mechanism of Mir- 7 enhancing sensitivity to Gefitinib in lung adenocarcinomas
ZHAO Jungang , LU Jibin , MEN Wanfu , ZHANG Lei.Mechanism of Mir- 7 enhancing sensitivity to Gefitinib in lung adenocarcinomas[J].Journal of Modern Oncology,2012,20(6):1113-1116.
Authors:ZHAO Jungang  LU Jibin  MEN Wanfu  ZHANG Lei
Institution:Department of Thoracic Surgery,Shengjing Hospital,China Medical University,liaoning Shenyang 110004,China
Abstract:Objective :To investigate if the cell’s sensitivity to Gefitinib can be enhanced by up-regulated Mir-7’s expression level and its mechanism in the human lung adenocarcinoma cell(A549 cell).Methods: The A549 cells were transfected by using lipofectamine2000 carry with the Mir-7 to and acted to Gefitinib.A549 cells were devided into 4 groups: transfection,Gefitinib,union and control.The proliferation of the cells was detected by 4-methyl-tetrazolium(MTT).E-Cadherin and N-Cadherin’s mRNA was detected by Real time PCR.Their protein’s expression was detected by Western blot.Results: The up-regulated Mir-7’s expression level of A549 cell with Gefitinib had more noticeable inhibition effect than Gefitinib alone.The cell’s invasiveness was decreased after Mir-7 transfection.There were no changes of expression E-Cadherin’s message RNA and protein in the transfection group and union group but the N-Cadherin’s decreased obviously.Conclusion: Mir-7 can enhance the cell’s sensitivity to Gefitinib.The mechanism of this phenomenon was the over-expressed Mir-7 can inhibit the epithelial-to-mesenchymal transition(EMT).
Keywords:non-small-cell carcinoma  Gefitinib  Mir-7  Cadherin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号